MYC and neoplasm: We also assayed how elevated expression of c-MYC in MSC would affect their bone tissue formation ability in vivo and whether it might enforce a potential risk of tumor formation in recipients, to address the concerns about consequent implications for therapeutic compatibility of these cells.